President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Clinical Research50-Year Medalist Study
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

Pharmaceutical and Device Companies

Pharmaceutical and medical device companies have an ongoing challenge reaching and educating providers and patients. In the world of diabetes, developments in the field - including new therapies, clinical approaches, and education interventions - are constantly changing. This dynamic environment requires companies to connect with its stakeholders with the highest quality information and most effective communication approaches in order to succeed.

For over 100 years, Joslin has pioneered diabetes research, care and education, and has created programs that inform providers and patients using the highest quality content and methods. With access to the world’s leading diabetes clinicians, researchers and educators as a Harvard Medical Affiliate, Joslin develops education programs that generate measurable impact with providers and patients. Through continuing medical education, to value-added programs, to clinical trial services, Joslin is actively working with companies to offer their target audiences the best information and education for diabetes and its co-morbidities.

Contact Information

For more information on how Joslin can provide health solutions for your company - from the world’s leading diabetes CME programs to other innovative services - please contact

Matthew Verlinden  
Healthcare Services

or email
Matthew Verlinden

Page last updated: October 14, 2019